• 1. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 2. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 3. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 4. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzophenones

Comprehensive Guide to (3-Fluorophenyl)(3-Methoxyphenyl)Methanone (CAS 120553-05-1): Properties, Applications, and Market Insights

(3-Fluorophenyl)(3-methoxyphenyl)methanone (CAS 120553-05-1) is a specialized aromatic ketone compound with growing importance in pharmaceutical and material science research. This fluorinated methanone derivative features a unique molecular structure combining 3-fluorophenyl and 3-methoxyphenyl groups, making it valuable for various synthetic applications. The compound's molecular formula C14H11FO2 and molecular weight 230.24 g/mol position it as an intermediate of significant interest in modern organic chemistry.

The growing demand for fluorinated organic compounds in drug discovery has increased attention on (3-fluorophenyl)(3-methoxyphenyl)methanone synthesis. Researchers particularly value its electron-withdrawing fluorine and electron-donating methoxy groups, which allow precise modulation of electronic properties in molecular design. Recent studies highlight its potential as a building block for bioactive molecules, especially in developing CNS-targeting pharmaceuticals and advanced material precursors.

From a physicochemical perspective, CAS 120553-05-1 typically appears as a white to off-white crystalline powder with moderate solubility in common organic solvents. Its melting point range (typically 85-90°C) and stability profile make it suitable for various laboratory-scale reactions and industrial applications. The compound's UV absorption characteristics (λmax ~260-280 nm) are particularly relevant for analytical method development and quality control procedures.

In pharmaceutical research, this methanone derivative serves as a key intermediate for developing novel therapeutic agents. Its structural features are being explored in neurological drug candidates, with particular interest in serotonin receptor modulators and dopamine pathway regulators. The 3-fluorophenyl moiety enhances metabolic stability, while the 3-methoxyphenyl group contributes to specific binding interactions—a combination addressing current challenges in CNS drug bioavailability.

The material science applications of (3-fluorophenyl)(3-methoxyphenyl)methanone are gaining traction in developing advanced polymer additives and liquid crystal materials. Its dipolar character and thermal stability make it valuable for creating high-performance specialty polymers with tailored optical and electronic properties. Recent patents highlight its use in OLED materials and organic semiconductors, aligning with the growing demand for flexible electronics and energy-efficient displays.

Market analysis indicates steady growth in demand for CAS 120553-05-1, particularly from contract research organizations and specialty chemical manufacturers. The compound's global market price trends reflect its niche status, with pricing influenced by fluorination process costs and pharmaceutical industry demand cycles. Current supply chain dynamics show increasing production in Asian specialty chemical hubs, with stringent quality control standards being implemented to meet GMP requirements for pharmaceutical intermediates.

From a synthetic chemistry perspective, several routes exist for preparing (3-fluorophenyl)(3-methoxyphenyl)methanone, including Friedel-Crafts acylation of appropriate precursors. Recent methodological advances focus on catalyst optimization and green chemistry approaches to improve yield and reduce environmental impact. The compound's purification challenges (particularly isomer separation) remain an active area of process chemistry research, with chromatographic techniques and crystallization optimization being key focus areas.

Analytical characterization of 120553-05-1 typically involves HPLC analysis, GC-MS, and NMR spectroscopy (particularly 19F NMR for quality assessment). The compound's spectral fingerprints are well-documented in chemical databases, facilitating its identification in complex reaction mixtures. Recent advancements in analytical method development have improved detection limits for related substances, crucial for meeting pharmaceutical impurity standards.

Regulatory aspects of (3-fluorophenyl)(3-methoxyphenyl)methanone vary by jurisdiction, with most regions classifying it as a general chemical substance. Proper handling procedures should follow standard laboratory safety protocols, including appropriate personal protective equipment. While not considered highly hazardous, its material safety data sheet recommends precautions against dust inhalation and eye contact during handling operations.

Future research directions for CAS 120553-05-1 include exploring its potential in catalytic asymmetric synthesis and as a precursor for metal-organic frameworks (MOFs). The compound's structural versatility continues to attract interest from medicinal chemists and materials scientists alike. With the pharmaceutical industry's growing focus on fluorine-containing drugs and the electronics sector's demand for specialty organic materials, this methanone derivative is poised for expanded applications in coming years.

• 345-89-1((4-Fluorophenyl)(4-methoxyphenyl)methanone)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)